MODL-47. A NEW MOUSE MODEL OF IDH MUTATED GLIOMAS IDENTIFIES TUMOR CELLS OF ORIGIN AND DETERMINANTS OF SENSITIVITY TO IDH INHIBITORS
Eric Laugesen(Princess Margaret Cancer Centre), Jérôme Fortin(Princess Margaret Cancer Centre), Uri Tabori(Universität Hamburg), Mario L. Suvà(Broad Institute), Kevin Petrecca(McGill University Health Centre), Samuel K. McBrayer(The University of Texas Southwestern Medical Center), Daniel Schramek(Mount Sinai Hospital), Annette Wu(Princess Margaret Cancer Centre), Samah El Ghamrasni(Princess Margaret Cancer Centre), Liana Nobre(Hospital for Sick Children), Cynthia Hawkins(Hospital for Sick Children), Zoya Aamir(Hospital for Sick Children), Tak W. Mak(University Health Network), Ruxiao Tian(Princess Margaret Cancer Centre), Adrian Levine(Hospital for Sick Children)
Cited by 3
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq
|Science|2017|1.1k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Regulation of tumour necrosis factor signalling: live or let die
|Nature reviews. Immunology|2015|994